These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6651020

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer.
    Umsawasdi T, Valdivieso M, Booser DJ, Barkley HT, Ewer M, MacKay B, Dhingra HM, Murphy WK, Spitzer G, Chiuten DF.
    Cancer; 1989 Nov 15; 64(10):1995-2000. PubMed ID: 2553235
    [Abstract] [Full Text] [Related]

  • 3. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM, Bristow MM, Lum BL, Carter SK, Howes AE, Aston DA, Brown BW, Hannigan JF, Meyers FJ, Mitchell EP.
    Cancer Res; 1986 Jul 15; 46(7):3722-7. PubMed ID: 3458531
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease.
    Mortensen SA, Olsen HS, Baandrup U.
    Br Heart J; 1986 Mar 15; 55(3):274-82. PubMed ID: 3456785
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.
    Friedman MA, Bozdech MJ, Billingham ME, Rider AK.
    JAMA; 1978 Oct 06; 240(15):1603-6. PubMed ID: 691145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy.
    Bristow MR, Mason JW, Billingham ME, Daniels JR.
    Am Heart J; 1981 Oct 06; 102(4):709-18. PubMed ID: 7282516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ, Doroshow JH, Venkataraman K, Chang K, Raschko J, Somlo G, Leong L, Tetef M, Shibata S, Hamasaki V, Margolin K, Forman S, Akman S, Coluzzi P, Ahn C, Weiss L, Gadgil U, Harrison J.
    Clin Cancer Res; 1997 Dec 06; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [Abstract] [Full Text] [Related]

  • 14. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB, Petitier H, Delajartre AY, Fumoleau P, Rozo L, Nicolas G.
    Arch Mal Coeur Vaiss; 1983 Nov 06; 76(11):1277-83. PubMed ID: 6419695
    [Abstract] [Full Text] [Related]

  • 15. Expectations and limitations of endomyocardial biopsy.
    Mills AS, Hastillo A, Thompson JA, Hess ML.
    Can J Cardiol; 1985 Nov 06; 1(6):358-62. PubMed ID: 3915878
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
    Hortobagyi GN, Frye D, Buzdar AU, Ewer MS, Fraschini G, Hug V, Ames F, Montague E, Carrasco CH, Mackay B.
    Cancer; 1989 Jan 01; 63(1):37-45. PubMed ID: 2910423
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.